1. Stocks
    2. /
  2. Immutep Limited (ASX: IMM)
    3. /

Immutep Limited (ASX: IMM) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Immutep Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Immutep Limited (ASX: IMM)
    Latest News

    A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
    ESG

    3 ethical ASX shares poised to outperform in 2024

    | Bernd Struben

    This leading fund manager sees strong potential gains ahead in 2024 for these three ethical ASX shares.

    Read more »

    A woman gives two fist pumps with a big smile as she learns of her windfall, sitting at her desk.
    Healthcare Shares

    Guess which ASX All Ords stock is jumping 16% on 'promising' results

    | James Mickleboro

    Investors are getting excited about this biotech company's announcement. What did it say?

    Read more »

    Two happy scientists analysing test results in a lab
    Healthcare Shares

    4 things to look for when buying ASX healthcare shares

    | Bronwyn Allen

    Fidelity's Zara Lyons tells us what to look for when researching and selecting ASX healthcare stocks for investment.

    Read more »

    A boy boots the ball past his parents in a game of backyard soccer.
    Healthcare Shares

    Here's why this ASX All Ords share has 'a number of shots at goal'

    | Bernd Struben

    The ASX All Ords share is well placed for future growth, according to this leading fund manager.

    Read more »

    a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.
    Share Fallers

    Why Adairs, Bubs, Immutep, and Lovisa shares are dropping today

    | James Mickleboro

    These ASX shares are ending the week in the red.

    Read more »

    A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
    Share Fallers

    Why Fisher & Paykel, Immutep, Latitude, and Universal Store shares are falling

    | James Mickleboro

    These ASX shares are ending the week in the red...

    Read more »

    A couple are shocked and elated at the good news they've just seen on their devices.
    Share Gainers

    Why Adbri, Costa, Delta Lithium, and Immutep shares are racing higher

    | James Mickleboro

    These ASX shares are having a strong session despite the market volatility.

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why Immutep, Leo Lithium, Playside, and Webjet shares are storming higher

    | James Mickleboro

    These ASX shares are avoiding the market weakness and storming higher.

    Read more »

    A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital
    Healthcare Shares

    Why has this ASX healthcare share exploded 50% in two days?

    | Monica O'Shea

    The biotech company is riding high on the back of promising clinical trial data.

    Read more »

    Health workers shake hands and congratulate each other on good news.
    Healthcare Shares

    2 ASX healthcare shares smashing the All Ords today

    | James Mickleboro

    These healthcare shares are smashing the All Ords today...

    Read more »

    A CSL scientist looking through a telescope in a lab
    Healthcare Shares

    What's the outlook for Immutep shares in FY23?

    | Zach Bristow

    The biotech company continues its clinical trial momentum.

    Read more »

    Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
    Healthcare Shares

    What's the outlook for ASX biotech shares in FY23?

    | Zach Bristow

    ASX biotech shares could be changing course in FY23.

    Read more »

    Frequently Asked Questions

    No, Immutep does not pay dividends at this time.

    Immutep Ltd listed on the ASX on 23 June 1988.

    IMM ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Immutep Limited

    Immutep Ltd (ASX: IMM) is a biotechnology company developing immunotherapy products for cancer and autoimmune diseases. The company describes itself as a pioneer in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system. Immutep's LAG-3 immunotherapies are designed to harness and strengthen the power of patients' immune systems to fight cancer and autoimmune diseases. Immutep currently has three clinical-stage candidates and two earlier-stage candidates.

    Profile

    since

    Note